51Talk Online Education Group to Report Second Quarter 2023 Financial Results on Friday, August 25, 2023

51Talk Online Education Group to Report Second Quarter 2023 Financial Results on Friday, August 25, 2023

Earnings Call Scheduled for 8:00 a.m. EST on August 25, 2023 SINGAPORE, Aug. 23, 2023 /PRNewswire/ -- 51Talk Online Education Group ("51Talk", or the "Company") (NYSEAMERICAN: COE), a global online education platform with core expertise in English...

Yeahka Limited to Report 2023 Interim Results on Thursday, August 24, 2023

Yeahka Limited to Report 2023 Interim Results on Thursday, August 24, 2023

HONG KONG, Aug. 16, 2023 /PRNewswire/ -- Yeahka Limited ("Yeahka" or the "Company", stock code: 9923.HK), a leading payment-based technology platform in China, today announced that it will report its unaudited financial results for the six months...

Boqii to Hold Extraordinary General Meeting on September 11, 2023

Boqii to Hold Extraordinary General Meeting on September 11, 2023

SHANGHAI, Aug. 5, 2023 /PRNewswire/ -- Boqii Holding Limited ("Boqii" or the "Company") (NYSE: BQ), a leading pet-focused platform in China, today announced that it will hold an extraordinary general meeting (the "EGM") on Monday, September 11, 2023...

Inaugural World NTM Awareness Day Marks 20-Year Anniversary and Honors Founders' Mission on August 4, 2023

Inaugural World NTM Awareness Day Marks 20-Year Anniversary and Honors Founders' Mission on August 4, 2023

MIAMI, Aug. 4, 2023 /PRNewswire/ -- NTM Info & Research (www.ntminfo.org), a pioneering global organization committed to addressing NonTuberculous Mycobacterial (NTM) and improving respiratory health, proudly announces the first-ever World NTM...

YS Biopharma Announces Financial Results for Fiscal Year 2023 Ended March 31, 2023

YS Biopharma Announces Financial Results for Fiscal Year 2023 Ended March 31, 2023

Total revenues increase by 36.3% year-over-year; gross margin improves to 77.7%; balance sheet remains robust Company's PIKA rabies vaccine approved for Phase III clinical trials in Singapore, the Philippines, and Pakistan; interim results expected...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 13
  • menu
    menu